Skip to main content
Allergy, Asthma & Immunology Research logoLink to Allergy, Asthma & Immunology Research
. 2017 Sep 28;10(1):77–82. doi: 10.4168/aair.2018.10.1.77

T-Helper Type 2 Cells Direct Antigen-Induced Eosinophilic Skin Inflammation in Mice

Osamu Kaminuma 1,2,3,4,, Tomoe Nishimura 2, Noriko Kitamura 2, Mayumi Saeki 2,4, Takachika Hiroi 2, Akio Mori 2,3
PMCID: PMC5705487  PMID: 29178680

Abstract

Eosinophilic inflammation in combination with immunoglobulin E (IgE) production is a characteristic feature of atopic dermatitis. Although activated T-helper type (Th) 2 cells play critical roles in the local accumulation and activation of eosinophils, whether they induce eosinophilic skin inflammation, independent of the IgE-mediated pathway has been unclear. To address the functional role of T cells in allergic skin diseases, we herein transferred Th1/Th2-differentiated or naive DO11.10 T cells into unprimed BALB/c mice. Ovalbumin-specific Th2 cells, as well as eosinophils, accumulated in the skin upon antigen challenge, despite the absence of antigen-specific IgE. Neither antigen-specific Th1 nor naive T cells induced eosinophil accumulation, although Th1 cells by themselves migrated into the skin. Interleukin (IL)-4, IL-5, and eotaxin were specifically produced in the skin of antigen-challenged, Th2 cell-transferred mice, whereas interferon (IFN)-γ and regulated on activation, normal T cell expressed and secreted (RANTES) were preferentially produced in Th1 cells-transferred mice. Production of monocyte chemoattractant protein (MCP)-1 and MCP-3 was enhanced by both Th1 and Th2 cells. The accumulation of eosinophils and Th2 cells in the skin was suppressed by both dexamethasone and FK506, indicating an essential role of Th2 cells in eosinophil recruitment. We conclude that Th2 cells can induce eosinophilic infiltration into the skin in the absence of antigen-specific IgE.

Keywords: Atopic dermatitis, chemokines, cytokines, eosinophils, immunoglobulin E, T-lymphocytes

INTRODUCTION

Eosinophils actively participate in the pathogenesis of allergic skin diseases.1,2 Extensive extracellular deposition of eosinophil major basic protein has been observed in the lesional skin of atopic dermatitis and chronic urticaria.3,4 A correlation has been demonstrated between eosinophil numbers, eosinophil cationic protein concentrations, or both, and the severity of atopic dermatitis.5,6,7 Eosinophil granule proteins possess cytotoxic activities,8 suggesting a potential mode of eosinophil contribution to dermal tissue damage in allergic skin diseases. Nevertheless, mechanisms responsible for the dermal infiltration of eosinophils remain unclear.

Immunoglobulin E (IgE) has been the most convincing candidate for the induction of eosinophilic skin inflammation because serum IgE levels are elevated in >80% of atopic dermatitis patients. Approximately 85% of patients have positive immediate skin test or radioallergosorbent test (RAST) results for specific IgE antibodies (Abs) in response to various allergens.9,10 Mast cells bearing IgE for the relevant antigen release eosinophil-activating mediators.11 Involvement of IgE in tissue eosinophilia was demonstrated using animal models of asthma.12 Nevertheless, concentrations of IgE are raised in most but not all patients with atopic dermatitis and do not necessarily correlate with disease severity.13,14 Animal studies demonstrating the non-essential role of humoral immunity in the development of eosinophilic inflammation also contradict the role of IgE.15,16,17,18 Taken together, the importance of IgE in the pathogenesis of eosinophilic inflammation in atopic dermatitis has become controversial.

Activated T-helper type (Th) 2 cells and Th2 cytokines are crucial for the infiltration and activation of eosinophils.19,20 The number of CD4+ T cells was increased in the skin lesions and peripheral blood of atopic dermatitis patients.21 In atopic dermatitis, the infiltrating CD4+ T cells appear to have a Th2 phenotype.22 A Th2 cytokine, interleukin (IL)-5, drives terminal differentiation of committed eosinophil precursors while also promoting eosinophil activation, chemotaxis, and prolonged survival,23 suggesting that IL-5 plays a central role in the induction of eosinophilic inflammation. However, it is not certain whether Th2 cells have the potential to induce atopic dermatitis-like eosinophilic skin inflammation without the assistance of IgE-mediated immune responses.

This study was performed to delineate the role of Th2 cells in the development of allergic eosinophilic inflammation in the skin by employing T-cell transfers in mice.

MATERIALS AND METHODS

Animals and in vitro polarization of T cells

Mice expressing DO11.10 TCRαβ, which recognizes residues 323-339 of ovalbumin (OVA), are described elsewhere.24 Male BALB/c mice at 6 to 8 weeks of age were obtained from Japan SLC, Inc. (Hamamatsu, Japan). OVA-specific Th1 and Th2 cells were generated from DO11.10 mice, using methods described previously.25,26 Successful differentiation of polarized cells was achieved using enzyme-linked immunosorbent assay (ELISA) and the intracellular staining of produced cytokines.25,26 Experimental procedures used in this study were approved by the Animal Use and Care Committee of Tokyo Metropolitan Institute of Medical Science.

Cell transfer and challenge procedures

The dorsal skin of BALB/c recipients was shaved with electric clippers and then depilatory cream was applied (Kanebo, Tokyo, Japan). Twenty-four hours later, the mice were anesthetized with inhaled halothane (1% v/v), and a dorsal shaved skin area 6 mm in diameter was irradiated (900 µW/cm2 at 254 nm) with an ultraviolet lamp (TK-151; Unicom, Chiba, Japan) for 1 minute. OVA-specific Th1, Th2, or naive DO11.10 T cells were stained with the fluorescein-based dye 5 (and 6)-carboxyfluorescein diacetate succinimidyl ester (CFSE; Molecular Probes, Eugene, OR, USA) by methods described previously.26,27 Then, 3×107 cells were injected into the tail vein of wildtype BALB/c mice. Twenty-four hours after the transfer, an aluminum rivet 9 mm in diameter was bonded to the shaved/irradiated area with cyanoacrylate adhesive (Toa Gousei, Tokyo, Japan) before being gently peeled off 10 minutes later. Then, a polypropylene cup-skin chamber 9 mm in diameter containing a sterile cotton pellet (30 mg) with 0.3 mL OVA solution (300 µg/mL in heparinized saline, 10 U/mL) was bonded to the area. Control mice were challenged with bovine serum albumin (BSA). For inhibition studies, dexamethasone (Dex) and FK506 (FK) were suspended in saline containing 0.5% Tween-80 (Tokyo Kasei, Tokyo, Japan) and administered subcutaneously 30 minutes before OVA challenge.

Skin-chamber fluid (SCF)

Twenty-four hours after antigen challenge, mice were killed by overdose with ether anesthesia before the skin chamber was removed from the skin. The cotton pellet was disentangled using 2 mL of Hank's balanced salt solution (HBSS) containing 0.1% BSA for 1 hour at room temperature. The SCF was then transferred to a test tube and centrifuged (250×g) for 5 minutes at 4℃.

Cytokines in the resulting supernatant were determined by ELISA, employing rat anti-mouse IL-5 monoclonal Ab (mAb) (BD Biosciences, Franklin Lakes, NJ, USA) and anti-mouse MCP-3 Ab (R&D systems, Minneapolis, MN, USA) as the capture Abs and biotinylated rat anti-mouse IL-5 mAb and goat anti-mouse MCP-3 Ab (R&D systems) as the detecting Abs. IL-4 and interferon (IFN)-γ were assayed by Duo Set ELISA Development Systems (R&D systems), MCP-1 by OptEIA mouse MCP-1 ELISA set (BD Biosciences), eotaxin by Quantikine mouse Eotaxin ELISA kit (R&D systems), and regulated on activation, normal T cell expressed and secreted (RANTES) by AN'ALYZA mouse RANTES immunoassay kit (R&D systems), each according to the manufacturer's instructions. The minimum detectable concentrations were 5, 5, 20, 5, 2, 5, and 50 pg/mL for IL-4, IL-5, IFN-γ, eotaxin, RANTES, MCP-1, and MCP-3, respectively.

The remaining cell pellet was immediately suspended in 250 µL of HBSS and the total cell number in the SCF was counted using an automatic cell counter (pocH-100iV; Sysmex, Hyogo, Japan). The number of CFSE-positive cells was counted using a FACSCantoII flow cytometer (BD Bioscience). Additional differential cell counting was performed by using microscopy on centrifuged preparations stained with May-Giemsa, counting 200 cells per animal.

Tissue eosinophil peroxidase (EPO) activity and histology

EPO activity in the skin was measured as previously described28 but with slight modifications. Briefly, after removing the skin chamber, the underlying skin was isolated by punch biopsy (10 mm diameter), and cut into fragments with a scalpel. Tissue fragments were suspended in 2 mL of 0.05 M Tris buffer (pH 8.0) containing 0.5% hexadecyltrimethylammonium bromide (Tris-HTAB) and homogenized using a Polytron homogenizer (Kinematica, Luzern, Switzerland) for 30 seconds. Homogenates were centrifuged (2,000×g) for 20 minutes at 20℃ then the supernatants were passed through a 0.45-µm filter. One volume of substrate solution (0.04% H2O2, 1.2 mg/mL o-phenylenediamine dihydrochloride in Tris-HTAB) was added to the filtered homogenate and mixed for 5 minutes at 20℃. The reaction was terminated by adding the same volume of 4 M H2SO4 and the absorbance at 492 nm was measured. Tissue EPO activity was expressed in units using standard horseradish peroxidase, whose specific activity was known.

The skin tissue was fixed in 10% neutral buffered formalin and paraffin-embedded. Sections (4 µm) were stained with hematoxylin and eosin for histologic analysis.

Statistical analysis

Data are presented as mean±standard error. Statistical analysis was performed by using Student's t test and one-way analysis of variance with Bonferroni's method. A P value of <0.05 was considered to indicate statistical significance.

RESULTS AND DISCUSSION

Whether Th2 cells are capable of recruiting eosinophils into the skin without the assistance of antigen-specific IgE was first investigated. CFSE-labeled Th1/Th2-differentiated or naive DO11.10 T cells were infused into unprimed mice, followed by OVA challenge. Twenty-four hours later, the number of CFSE+ cells (antigen-specific T cells) and eosinophils in the SCF as well as EPO activity in the skin were measured. In Th2 cell-transferred mice, the number of both eosinophils and antigen-specific T cells in the SCF was increased upon challenge with OVA, in comparison with that in BSA (Fig. 1A). In Th1 cell-transferred mice, antigen-specific T cells migrated into the SCF to an extent similar to that in Th2 cell-transferred mice, while antigen-induced eosinophil accumulation was much weaker. Infiltration of neither T cells nor eosinophils occurred in the mice transferred with naive T cells. In parallel with eosinophil accumulation, EPO activity in the skin was specifically induced in Th2 cell-transferred and OVA-challenged mice, suggesting that EPO activity is a reliable indicator of eosinophil recruitment into the tissues (Fig. 1A).

Fig. 1. induced migration of T cells and eosinophils in the skin tissues of OVA-reactive T cell-transferred mice. Naive or Th1/Th2-differentiated DO11.10 T cells (3×107) were stained with CFSE and transferred to wildtype mice by intravenous injection. After 24 hours, these mice were challenged with 300 µg/mL OVA or BSA. Twenty-four hours after challenge, the CFSE-positive, antigen-specific T cells and eosinophils in SCF and EPO activity in the skin tissues were measured (A). Data are expressed as the mean±SEM (n=5-6). Four days after challenge, a skin specimen was taken, stained with hematoxylin-eosin, and observed under optical microscopy (B). The low and high magnification images shown in the upper and lower panels, respectively, are representative of three-four animals. Representative eosinophils are indicated by arrow heads. Bar=50 µm. OVA, ovalbumin; Th, T-helper type; CFSE, 5 (and 6)-carboxyfluorescein diacetate succinimidyl ester; BSA, bovine serum albumin; SCF, skin-chamber fluid; EPO, eosinophil peroxidase; SEM, standard error of mean. *P<0.05; P<0.01 (Student's t test).

Fig. 1

Antigen-induced skin inflammation was evaluated in histological sections. In naive T cell-transferred mice, inflammatory cells were detectable only in small numbers even upon challenge with OVA (Fig. 1B). Consistent with the results of cell infiltration and tissue EPO activity, various inflammatory cells, including lymphocytes and neutrophils, but not eosinophils, migrated into the skin of Th1 cell-transferred mice (Fig. 1B). Obvious inflammatory features similar to the symptoms of atopic dermatitis patients, including massive accumulation of eosinophils, were seen in the skin of Th2 cell-transferred mice upon OVA challenge.

In these short-term experimental conditions, OVA-specific IgE was not detected in the skin or sera (data not shown), suggesting that eosinophilic skin inflammation could be induced by Th2 cells without assistance of IgE. Although hyper-IgE is a common feature of patients with atopic dermatitis,9,10 a dispensable role of IgE in the development of allergic inflammation was also confirmed in other target tissues, such as lungs, nasal mucosa, and intestine, in which massive eosinophil accumulation was seen in Th2 cell-transferred mice.25,29,30 Although obvious eosinophilic accumulation was not observed in OVA-specific IgE-transgenic mice even upon repeated antigen challenge,30 we have shown that the IgE/mast cell-dependent pathway plays a supplemental role in eosinophilic inflammation, by employing an antigen-immunized mouse model.17 The cooperation of Th2 cells and IgE in the pathology of atopic dermatitis deserves further investigation.

To elucidate mechanisms by which eosinophils and T cells migrate into the skin, cytokine concentrations in the SCF of T cell-transferred mice were next examined (Table). In accordance with the in vitro profiles of transferred T cells,25,26 IL-4, and IL-5 were specifically produced upon antigen challenge in the mice transferred with Th2 cells, whereas IFN-γ was preferentially produced in Th1 cell-transferred mice. Eotaxin concentration in the SCF production was increased only in Th2-transferred mice upon antigen challenge, whereas RANTES was produced only in Th1-transferred mice. MCP-1 and MCP-3 levels were increased by antigen challenge in both Th1 and Th2 cell-transferred mice.

Table. Antigen-induced cytokine and chemokine production in the SCF of DO11.10 T cell-transferred mice.

Cytokine and chemokine production (pg/mL)
Transfer Challenge IL-4 IL-5 IFN-γ Eotaxin RANTES MCP-1 MCP-3
Naive BSA 22.8±1.8 34.3±6.3 34±2 17.0±3.2 4.8±0.3 19.3±12.2 3,800±620
OVA 22.0±0.7 26.8±7.6 35±2 9.8±1.8 3.8±0.3 17.0±13.1 4,470±420
Th1 BSA 21.5±0.3 29.3±11.3 37±4 15.8±3.7 4.5±0.9 16.8±9.2 3,260±370
OVA 30.8±5.9 24.0±9.7 213±76* 15.8±2.6 52.3±5.2 60.3±13.2 5,560±430*
Th2 BSA 23.3±2.3 32.0±11.2 37±5 22.0±2.6 4.0±0.7 16.3±8.2 3,460±610
OVA 82.5±16.7* 82.3±27.1* 38±3 52.4±6.9 5.3±0.5 45.8±13.1* 5,200±90*

Naive or Th1/Th2-differentiated DO11.10 T cells (3×107) were transferred to wildtype mice by intravenous injection. After 24 hours, these mice were challenged with 300 µg/mL OVA or BSA using a skin chamber. Twenty-four hours after challenge, the concentrations of cytokines and chemokines in the SCF were measured.

Data are expressed as the mean±SEM (n=5-6).

SCF, skin-chamber fluid; IL, interleukin; IFN, interferon; RANTES, regulated on activation, normal T cell expressed and secreted; MCP, monocyte chemoattractant protein; BSA, bovine serum albumin; OVA, ovalbumin; Th, T-helper type; SEM, standard error of mean.

*P<0.05; P<0.01, compared with BSA-challenged control (Student's t test).

Eosinophils express high levels of CC chemokine receptor (CCR) 3,31,32 which binds several chemokines, including eotaxin, RANTES, and MCP-3. These chemokines are released from various tissues and cells in response to cytokine stimulation.33 It is intriguing that a significant recruitment of eosinophils was not seen in the skin of Th1 cell-transferred mice, in which substantial production of RANTES and MCP-3, as well as migration of Th1 cells themselves, were observed. A Th2-specific cytokine, IL-5, promotes eosinophil chemotactic activity.34,35 The cooperation of IL-5 and eotaxin in the accumulation of eosinophils has been demonstrated in vivo.36 Therefore, IL-5 activity might be important for the eosinophilic skin inflammation selectively induced by Th2 cells. Further studies are needed to elucidate the mechanisms and meaning of our new finding that eosinophil-active RANTES and MCP-3 are produced in Th1-mediated pathology without recruiting eosinophils.

To gain an insight into the relationship between the antigen-induced infiltration of eosinophils and T cells that occurred in Th2 cell-transferred mice, the effects of the immunosuppressants Dex and FK were next examined. As shown in Fig. 2, both agents similarly and dose-dependently suppressed antigen-induced infiltration of antigen-specific T cells and elevation of skin EPO activity in Th2 cell-transferred mice. These results support the clinical efficiency of Dex and FK for atopic dermatitis patients. Since these reagents strongly suppress activation of T cells but not eosinophils,37,38,39 it is suggested that skin-infiltrating, antigen-specific Th2 cells participate in the accompanying eosinophil migration.

Fig. 2. Effects of Dex and FK on antigen-induced Th2 cell migration and upregulation of EPO activity in the skin. Th2 cells (3×107) were transferred to wildtype mice by intravenous injection. After 24 hours, these mice were challenged with 300 µg/mL OVA or BSA. Indicated doses of Dex and FK were administered subcutaneously 30 minutes before challenge. Twenty-four hours after challenge, the number of CFSE-positive cells in the SCF and EPO activity in the skin tissues were measured. Data are expressed as the mean±SEM (n=5-6). Dex, dexamethasone; FK, FK506; Th, T-helper type; EPO, eosinophil peroxidase; OVA, ovalbumin; BSA, bovine serum albumin; CFSE, carboxyfluorescein diacetate succinimidyl ester; SCF, skin-chamber fluid; SEM, standard error of mean. *P<0.05 (Bonferroni's method).

Fig. 2

In conclusion, Th2 cells have the potential to develop eosinophilic skin inflammation, a representative pathological feature of atopic dermatitis, independent of an IgE-dependent pathway. Our new model of skin infiltration of antigen-specific Th2 cells and eosinophils in Th2 cell-transferred mice responds to Dex and FK and is expected to be useful for the generation of novel therapeutic treatments for atopic dermatitis, especially targeting Th2 cell-mediated and eosinophil-related pathogenesis.

ACKNOWLEDGMENTS

This work was supported by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (KAKENHI) (No. 15K07787) and funding from the Towa Foundation for Food Science & Research, the Hoyu Science Foundation, and the Tojuro Iijima Foundation for Food Science and Technology, to Osamu Kaminuma.

Footnotes

There are no financial or other issues that might lead to conflict of interest.

References

  • 1.Leiferman KM. Eosinophils in atopic dermatitis. J Allergy Clin Immunol. 1994;94:1310–1317. doi: 10.1016/0091-6749(94)90347-6. [DOI] [PubMed] [Google Scholar]
  • 2.Leiferman KM. A current perspective on the role of eosinophils in dermatologic diseases. J Am Acad Dermatol. 1991;24:1101–1112. doi: 10.1016/0190-9622(91)70166-y. [DOI] [PubMed] [Google Scholar]
  • 3.Ott NL, Gleich GJ, Peterson EA, Fujisawa T, Sur S, Leiferman KM. Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE-mediated late-phase reaction. J Allergy Clin Immunol. 1994;94:120–128. doi: 10.1016/0091-6749(94)90078-7. [DOI] [PubMed] [Google Scholar]
  • 4.Peters MS, Schroeter AL, Kephart GM, Gleich GJ. Localization of eosinophil granule major basic protein in chronic urticaria. J Invest Dermatol. 1983;81:39–43. doi: 10.1111/1523-1747.ep12538380. [DOI] [PubMed] [Google Scholar]
  • 5.Walker C, Kägi MK, Ingold P, Braun P, Blaser K, Bruijnzeel-Koomen CA, et al. Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity. Clin Exp Allergy. 1993;23:145–153. doi: 10.1111/j.1365-2222.1993.tb00310.x. [DOI] [PubMed] [Google Scholar]
  • 6.Czech W, Krutmann J, Schöpf E, Kapp A. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol. 1992;126:351–355. doi: 10.1111/j.1365-2133.1992.tb00677.x. [DOI] [PubMed] [Google Scholar]
  • 7.Kägi MK, Joller-Jemelka H, Wüthrich B. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology. 1992;185:88–92. doi: 10.1159/000247419. [DOI] [PubMed] [Google Scholar]
  • 8.Walsh GM. Eosinophil granule proteins and their role in disease. Curr Opin Hematol. 2001;8:28–33. doi: 10.1097/00062752-200101000-00006. [DOI] [PubMed] [Google Scholar]
  • 9.Hoffman DR, Yamamoto FY, Geller B, Haddad Z. Specific IgE antibodies in atopic eczema. J Allergy Clin Immunol. 1975;55:256–267. [Google Scholar]
  • 10.Sampson HA, Albergo R. Comparison of results of skin tests, RAST, and double-blind, placebo-controlled food challenges in children with atopic dermatitis. J Allergy Clin Immunol. 1984;74:26–33. doi: 10.1016/0091-6749(84)90083-6. [DOI] [PubMed] [Google Scholar]
  • 11.Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today. 1990;11:458–464. doi: 10.1016/0167-5699(90)90176-a. [DOI] [PubMed] [Google Scholar]
  • 12.Coyle AJ, Wagner K, Bertrand C, Tsuyuki S, Bews J, Heusser C. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody. J Exp Med. 1996;183:1303–1310. doi: 10.1084/jem.183.4.1303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Rudikoff D, Lebwohl M. Atopic dermatitis. Lancet. 1998;351:1715–1721. doi: 10.1016/S0140-6736(97)12082-7. [DOI] [PubMed] [Google Scholar]
  • 14.Park HJ, Kim EJ, Yoon D, Lee JK, Chang WS, Lim YM, et al. Prevalence of self-reported allergic diseases and IgE levels: a 2010 KNHANES analysis. Allergy Asthma Immunol Res. 2017;9:329–339. doi: 10.4168/aair.2017.9.4.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Mehlhop PD, van de Rijn M, Goldberg AB, Brewer JP, Kurup VP, Martin TR, et al. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci U S A. 1997;94:1344–1349. doi: 10.1073/pnas.94.4.1344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Hamelmann E, Takeda K, Schwarze J, Vella AT, Irvin CG, Gelfand EW. Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytes. Am J Respir Cell Mol Biol. 1999;21:480–489. doi: 10.1165/ajrcmb.21.4.3659. [DOI] [PubMed] [Google Scholar]
  • 17.Ogawa K, Kaminuma O, Kikkawa H, Kameda R, Ikezawa K, Suko M, et al. Primary role of CD4+ T cells and supplemental role of mast cells in allergic pulmonary eosinophilia. Int Arch Allergy Immunol. 1999;120(Suppl 1):15–18. doi: 10.1159/000053586. [DOI] [PubMed] [Google Scholar]
  • 18.Nishimura T, Saeki M, Kaminuma O, Matsuoka K, Yonekawa H, Mori A, et al. Existence of antigen-specific immunoglobulin E is not sufficient for allergic nasal eosinophil infiltration in mice. Int Arch Allergy Immunol. 2013;161(Suppl 2):125–128. doi: 10.1159/000350565. [DOI] [PubMed] [Google Scholar]
  • 19.Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today. 1992;13:501–507. doi: 10.1016/0167-5699(92)90026-4. [DOI] [PubMed] [Google Scholar]
  • 20.Kay AB. “Helper” (CD4+) T cells and eosinophils in allergy and asthma. Am Rev Respir Dis. 1992;145:S22–S26. doi: 10.1164/ajrccm/145.2_Pt_2.S22. [DOI] [PubMed] [Google Scholar]
  • 21.Lever R, Turbitt M, Sanderson A, MacKie R. Immunophenotyping of the cutaneous infiltrate and of the mononuclear cells in the peripheral blood in patients with atopic dermatitis. J Invest Dermatol. 1987;89:4–7. doi: 10.1111/1523-1747.ep12579727. [DOI] [PubMed] [Google Scholar]
  • 22.Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol Today. 1991;12:256–257. doi: 10.1016/0167-5699(91)90120-I. [DOI] [PubMed] [Google Scholar]
  • 23.Kouro T, Takatsu K. IL-5- and eosinophil-mediated inflammation: from discovery to therapy. Int Immunol. 2009;21:1303–1309. doi: 10.1093/intimm/dxp102. [DOI] [PubMed] [Google Scholar]
  • 24.Murphy KM, Heimberger AB, Loh DY. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science. 1990;250:1720–1723. doi: 10.1126/science.2125367. [DOI] [PubMed] [Google Scholar]
  • 25.Watanabe N, Kaminuma O, Kitamura N, Hiroi T. Induced Treg cells augment the Th17-mediated intestinal inflammatory response in a CTLA4-dependent manner. PLoS One. 2016;11:e0150244. doi: 10.1371/journal.pone.0150244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kaminuma O, Ohtomo T, Mori A, Nagakubo D, Hieshima K, Ohmachi Y, et al. Selective down-regulation of Th2 cell-mediated airway inflammation in mice by pharmacological intervention of CCR4. Clin Exp Allergy. 2012;42:315–325. doi: 10.1111/j.1365-2222.2011.03847.x. [DOI] [PubMed] [Google Scholar]
  • 27.Kaminuma O, Fujimura H, Fushimi K, Nakata A, Sakai A, Chishima S, et al. Dynamics of antigen-specific helper T cells at the initiation of airway eosinophilic inflammation. Eur J Immunol. 2001;31:2669–2679. doi: 10.1002/1521-4141(200109)31:9<2669::aid-immu2669>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  • 28.Pettipher ER, Salter ED, Showell HJ. Effect of in vivo desensitization to leukotriene B4 on eosinophil infiltration in response to C5a in guinea-pig skin. Br J Pharmacol. 1994;113:117–120. doi: 10.1111/j.1476-5381.1994.tb16182.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kaminuma O, Mori A, Ogawa K, Nakata A, Kikkawa H, Naito K, et al. Successful transfer of late phase eosinophil infiltration in the lung by infusion of helper T cell clones. Am J Respir Cell Mol Biol. 1997;16:448–454. doi: 10.1165/ajrcmb.16.4.9115756. [DOI] [PubMed] [Google Scholar]
  • 30.Nishimura T, Kaminuma O, Saeki M, Kitamura N, Matsuoka K, Yonekawa H, et al. Essential contribution of CD4+ T cells to antigen-induced nasal hyperresponsiveness in experimental allergic rhinitis. PLoS One. 2016;11:e0146686. doi: 10.1371/journal.pone.0146686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ponath PD, Qin S, Post TW, Wang J, Wu L, Gerard NP, et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med. 1996;183:2437–2448. doi: 10.1084/jem.183.6.2437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Daugherty BL, Siciliano SJ, DeMartino JA, Malkowitz L, Sirotina A, Springer MS. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med. 1996;183:2349–2354. doi: 10.1084/jem.183.5.2349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Velazquez JR, Teran LM. Chemokines and their receptors in the allergic airway inflammatory process. Clin Rev Allergy Immunol. 2011;41:76–88. doi: 10.1007/s12016-010-8202-6. [DOI] [PubMed] [Google Scholar]
  • 34.Warringa RA, Schweizer RC, Maikoe T, Kuijper PH, Bruijnzeel PL, Koendermann L. Modulation of eosinophil chemotaxis by interleukin-5. Am J Respir Cell Mol Biol. 1992;7:631–636. doi: 10.1165/ajrcmb/7.6.631. [DOI] [PubMed] [Google Scholar]
  • 35.Sehmi R, Wardlaw AJ, Cromwell O, Kurihara K, Waltmann P, Kay AB. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood. 1992;79:2952–2959. [PubMed] [Google Scholar]
  • 36.Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med. 1995;182:1169–1174. doi: 10.1084/jem.182.4.1169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Kita H, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ. Effect of steroids on immunoglobulin-induced eosinophil degranulation. J Allergy Clin Immunol. 1991;87:70–77. doi: 10.1016/0091-6749(91)90214-9. [DOI] [PubMed] [Google Scholar]
  • 38.Hossain M, Okubo Y, Sekiguchi M. Effects of various drugs (staurosporine, herbimycin A, ketotifen, theophylline, FK506 and cyclosporin A) on eosinophil viability. Arerugi. 1994;43:711–717. [PubMed] [Google Scholar]
  • 39.Mori A, Suko M, Nishizaki Y, Kaminuma O, Kobayashi S, Matsuzaki G, et al. IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. Int Immunol. 1995;7:449–457. doi: 10.1093/intimm/7.3.449. [DOI] [PubMed] [Google Scholar]

Articles from Allergy, Asthma & Immunology Research are provided here courtesy of Korean Academy of Asthma, Allergy and Clinical Immunology and Korean Academy of Pediatric Allergy and Respiratory Disease

RESOURCES